English | Russian | Kazakh
ONCOLOGY, NUCLEAR MEDICINE AND TRANSPLANTOLOGY
Original Article

Effect of Aqueous Extracts of Kigelia africana and Acacia nilotica on Selected Tumour Markers in Diethylnitrosamine-Induced Liver Cell Dysplasia in Wistar Rats

Oncology, Nuclear Medicine and Transplantology, 2(3), 2026, onmt023, https://doi.org/10.63946/onmt/18977
Publication date: Jul 17, 2026
Full Text (PDF)

ABSTRACT

ABSTRACT
Background: Diethylnitrosamine (DEN) is a nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties that causes major liver damage and acts as a hepatocarcinogen in rodents. Acacia nilotica and Kigelia africana are plants used in local communities to treat wounds and ulcers.
Objective: This study investigated the effect of aqueous extracts of Kigelia africana and Acacia nilotica on alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), and cancer antigen 125 (CA-125) levels in DEN-induced liver cell dysplasia in Wistar rats.
Methods: Forty (40) male Wistar rats, aged 6–8 weeks, were divided into eight (8) groups of five (5) animals each. Liver cell dysplasia was induced with a single intraperitoneal dose of DEN (100 mg/kg) and promoted with oral phenobarbitone (0.25 mg/kg) twice weekly, beginning one week after induction. Group I received clean drinking water; group II received DEN only; group III received DEN + phenobarbitone; groups IV and V received DEN + phenobarbitone + 250 mg/kg and 500 mg/kg of Acacia nilotica respectively; groups VI and VII received DEN + phenobarbitone + 250 mg/kg and 500 mg/kg of Kigelia africana respectively; and group VIII received DEN + phenobarbitone + 10 mg/kg of sorafenib. Blood samples were collected on day 120 for biomarker evaluation, and liver tissue was processed for histopathology.
Results: CEA and CA-125 differed significantly among groups (p < 0.001), although group means largely remained within the physiological reference range; AFP showed no significant difference (p = 0.580). The highest CEA values occurred in the DEN-only and DEN + phenobarbitone groups, while CA-125 was highest in the DEN-only and sorafenib-treated groups. Animals treated with the plant extracts, particularly at the higher dose (500 mg/kg), maintained CEA and CA-125 values close to those of the negative control. Histopathology showed dose-dependent attenuation of DEN-induced changes by both extracts, with the higher dose of Kigelia africana producing near-normal liver architecture.
Conclusion: Both extracts, especially at higher doses, appeared chemoprotective against DEN-induced hepatic changes, supporting further investigation of their underlying mechanisms.

KEYWORDS

Liver Dysplasia Carcinoembryonic Antigen Alpha-Fetoprotein Cancer Antigen 125 Diethylnitrosamine

CITATION (Vancouver)

Aniah JA, Inyang BA. Effect of Aqueous Extracts of Kigelia africana and Acacia nilotica on Selected Tumour Markers in Diethylnitrosamine-Induced Liver Cell Dysplasia in Wistar Rats. Oncology, Nuclear Medicine and Transplantology. 2026;2(3):onmt023. https://doi.org/10.63946/onmt/18977
APA
Aniah, J. A., & Inyang, B. A. (2026). Effect of Aqueous Extracts of Kigelia africana and Acacia nilotica on Selected Tumour Markers in Diethylnitrosamine-Induced Liver Cell Dysplasia in Wistar Rats. Oncology, Nuclear Medicine and Transplantology, 2(3), onmt023. https://doi.org/10.63946/onmt/18977
Harvard
Aniah, J. A., and Inyang, B. A. (2026). Effect of Aqueous Extracts of Kigelia africana and Acacia nilotica on Selected Tumour Markers in Diethylnitrosamine-Induced Liver Cell Dysplasia in Wistar Rats. Oncology, Nuclear Medicine and Transplantology, 2(3), onmt023. https://doi.org/10.63946/onmt/18977
AMA
Aniah JA, Inyang BA. Effect of Aqueous Extracts of Kigelia africana and Acacia nilotica on Selected Tumour Markers in Diethylnitrosamine-Induced Liver Cell Dysplasia in Wistar Rats. Oncology, Nuclear Medicine and Transplantology. 2026;2(3), onmt023. https://doi.org/10.63946/onmt/18977
Chicago
Aniah, Julius Akomaye, and Bassey Atte Inyang. "Effect of Aqueous Extracts of Kigelia africana and Acacia nilotica on Selected Tumour Markers in Diethylnitrosamine-Induced Liver Cell Dysplasia in Wistar Rats". Oncology, Nuclear Medicine and Transplantology 2026 2 no. 3 (2026): onmt023. https://doi.org/10.63946/onmt/18977
MLA
Aniah, Julius Akomaye et al. "Effect of Aqueous Extracts of Kigelia africana and Acacia nilotica on Selected Tumour Markers in Diethylnitrosamine-Induced Liver Cell Dysplasia in Wistar Rats". Oncology, Nuclear Medicine and Transplantology, vol. 2, no. 3, 2026, onmt023. https://doi.org/10.63946/onmt/18977

REFERENCES

  1. Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol. 1973;26(3):217-23. https://doi.org/10.1136/jcp.26.3.217
  2. Choi JH, Thung SN. Pathology and diagnostic approaches to well-differentiated hepatocellular lesions: a narrative review. J Yeungnam Med Sci. 2024;42:e2024.00766. doi:10.12701/jyms.2024.00766
  3. Liao Z, Tang C, Luo R, Gu X, Zhou J, Gao J. Current concepts of precancerous lesions of hepatocellular carcinoma: recent progress in diagnosis. Diagnostics (Basel). 2023;13(7):1211. doi:10.3390/diagnostics13071211
  4. Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z, et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct Target Ther. 2025;10:33. doi:10.1038/s41392-024-02072-z
  5. Lala V, Zubair M, Minter DA. Liver function tests. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026.
  6. Kruepunga N, Hakvoort TBM, Hikspoors JPJM, Köhler SE, Lamers WH. Anatomy of rodent and human livers: what are the differences? Biochim Biophys Acta Mol Basis Dis. 2019;1865(5):869-78. doi:10.1016/j.bbadis.2018.05.019
  7. Kalra A, Yetiskul E, Wehrle CJ, Tuma F. Physiology, liver. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026.
  8. Institute for Quality and Efficiency in Health Care (IQWiG). In brief: how does the liver work? In: InformedHealth.org. Cologne: IQWiG; 2023.
  9. Edoo MIA, Chutturghoon VK, Wusu-Ansah GK, Zhu H, Zhen TY, Xie HY, et al. Serum biomarkers AFP, CEA and CA19-9 combined detection for early diagnosis of hepatocellular carcinoma. Iran J Public Health. 2019;48(2):314-22.
  10. Głowska-Ciemny J, Szmyt K, Kuszerska A, Rzepka R, von Kaisenberg C, Kocyłowski R. Fetal and placental causes of elevated serum alpha-fetoprotein levels in pregnant women. J Clin Med. 2024;13(2):466. doi:10.3390/jcm13020466
  11. Lai Q, Iesari S, Melandro F, Mennini G, Rossi M, Lerut J. The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution. Transl Gastroenterol Hepatol. 2017;2:72. doi:10.21037/tgh.2017.09.05
  12. Bălăceanu LA, Grigore C, Dina I, Gurău CD, Mihai MM, Bălăceanu-Gurău B. CA125 as a potential biomarker in non-malignant serous effusions: diagnostic and prognostic considerations. J Clin Med. 2025;14(12):4152. doi:10.3390/jcm14124152
  13. Li S, Li Y, Sun H, Jiang Y, Pan K, Su Y, et al. Mulberry fruit polysaccharides alleviate diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis in vivo: the roles of cell apoptosis and inflammation. Bioengineered. 2021;12(2):11599-611. doi:10.1080/21655979.2021.1993716
  14. Hussein UK, Mahmoud HM, Farrag AG, Bishayee A. Chemoprevention of diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis in rats by sulfated polysaccharides and aqueous extract of Ulva lactuca. Integr Cancer Ther. 2015;14(6):525-45. doi:10.1177/1534735415590157
  15. Yeo YH, Lee YT, Tseng HR, Zhu Y, You S, Agopian VG, et al. Alpha-fetoprotein: past, present, and future. Hepatol Commun. 2024;8(5):e0422. doi:10.1097/HC9.0000000000000422

LICENSE

Creative Commons License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.